Funding for this research was provided by:
Bank of Canada (OPP1137180)
Received: 6 March 2019
Accepted: 30 September 2019
First Online: 15 October 2019
Ethics approval and consent to participate
: The study was approved by the ethics committee of the Chinese Center for Disease Control and Prevention (201626). Physicians introduced the advantages of the EMM to all participating patients, allowing the patients to select their preferred management approach, the verbal consent of using EMM was obtained at the BMU. If the patients consent to use EMM, they were required to sign a consent form later by the community physicians at the first home visit. If the patients declined to use the EMM, DOT was offered.
: Not applicable.
: The authors declare that they have no competing interests.